This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignees: Karlsruhe Institute of Technology, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2024.
Company Filing History:
1 out of 181 
1 out of 1,330 
Years Active: 2024
Title: Joanna Napp: Innovator in Inorganic-Organic Hybrid Compounds
Introduction
Joanna Napp is a distinguished inventor based in Rosdorf, Germany. She has made significant contributions to the field of medicine through her innovative work on inorganic-organic hybrid compounds. Her research focuses on the development of compounds that can be utilized as medication, particularly in the realm of cancer treatment.
Latest Patents
Joanna Napp holds a patent for "Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine." This invention relates to hybrid compounds that consist of an inorganic metal cation and an organic platinum-containing cytostatic anion, specifically a cisplatin derivative. This groundbreaking work has the potential to enhance therapeutic options in medical treatments.
Career Highlights
Throughout her career, Joanna has worked with prestigious institutions such as the Karlsruhe Institute of Technology and the Max Planck Society for the Advancement of Science. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to significant advancements in medical research.
Collaborations
Joanna has collaborated with notable colleagues, including Beatrice Lilli Neumeier and Claus Feldmann. These partnerships have fostered a rich environment for innovation and have led to the development of impactful research in the field of medicine.
Conclusion
Joanna Napp's work in developing inorganic-organic hybrid compounds represents a significant advancement in medical science. Her contributions are paving the way for new treatment options and showcasing the importance of innovation in healthcare.